Charles River Laboratories has opened its new biomedical diagnostic testing facility in Wilmington, MA. The 60,000-sq.-ft. R&D services facility expands the company’s diagnostic capabilities for research model health monitoring, clinical chemistry, hematology, biomarker assay development and immunoassay services. The facility offers controlled environments, building monitoring and mechanical systems redundancy, and energy efficiency.
 
“Our new facility provides Charles River with additional capacity for growth, as well as the capability to utilize innovative technology platforms to advance the high-quality R&D services we provide our biopharmaceutical and academic clients,” said James C. Foster, chairman, president and chief executive officer. “The opening of this building also demonstrates our commitment to investing in growth businesses and our employees, as well as doing business in the Commonwealth of Massachusetts.”